Biphasic Insulin Aspart 70/30

insulin aspart 70/30 · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Biphasic Insulin Aspart 70/30, covering 2017-01-05 to 2017-02-24. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Male Subjects [Phase 1]